OpenResearchAlpha

bioRxiv · 11 Nov 2026

HIV broadly neutralizing antibody precursor maturation induced by mRNA vaccination in nonhuman primates

Ivy Phung, Brian L. Freeman, Alessia Liguori, Amber Seymour, Zhenfei Xie, Swastik Phulera, Oleksandr Kalyuzhniy, Patrick J. Madden, Ester Marina-Zarate, Jordan R. Willis, Christopher A. Cottrell, Krystal M. Ma, Sabyasachi Baboo, Claudia T. Flynn, Carolyne Kifude, Danny Lu, Nicole Phelps, Diana Goodwin, Yumiko Adachi, Ryan Tingle, Erik Georgeson, Jenny Tran, Anton Kalyuzhniy, Xiaozhen Hu, Vanessa R. Lewis, Julia T. Ngo, Xiaotie Liu, Jolene K. Diedrich, Usha Nair, Sunny Himansu, Torben Schiffner, Paolo Lusso, James C. Paulson, John R. Yates, Diane G. Carnathan, Dennis R. Burton, Darrell J. Irvine, Guido Silvestri, Andrew B. Ward, Gabriel Ozorowski, Facundo D. Batista, Parham Ramezani-Rad, Jon M. Steichen, Shane Crotty, William R. Schief

0
Citations
no database records one yet
0
Citations in 2026
so far
–
Leading author's h-index
no author has a profile yet
0
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

The induction of broadly neutralizing antibodies (bnAbs) is a principal goal of prophylactic HIV vaccines. For many bnAbs, priming ultrarare precursors from the naive B cell repertoire is the first major immunological hurdle. Previous studies have shown that the germline-targeting (GT) priming immunogen N332-GT5 delivered as adjuvanted protein to non-human primates (NHPs) activates bnAb precursor B cells for the human bnAb BG18 targeting the V3-glycan supersite on the HIV envelope (Env) glycoprotein. Here, we engineered N332-GT6 to improve binding affinity to diverse BG18-class precursor naive B cells by 9-fold. mRNA-LNP vaccines expressing N332-GT5 or N332-GT6 as membrane-bound (gp151) trimers were evaluated for their ability to prime BG18-class precursor B cells in NHPs across three related studies. Although N332-GT5 gp151 mRNA-LNP priming induced BG18-class precursor B cells in most animals after two vaccinations, the higher-affinity N332-GT6 gp151 induced responses more consistently after only one immunization. Sequential vaccination with two heterologous mRNA-LNP booster immunizations drove affinity maturation and induced BG18-class memory B cells capable of binding wildtype HIV Env. Together, these findings demonstrate that mRNA immunization can achieve GT priming, boosting, and early maturation of ultrarare bnAb-class B cells in NHPs.

Immunology

What the data shows

  • No database records a citation yet, as is usual for a paper this new.

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (45)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (0)

What it cites, from open citation data, with Crossref's record of each.

No references in the open citation data yet.